Glucocorticoids are central to effective therapy of acute graft-versus-host disease (GVHD). However, only about half of the patients respond to steroids in initial therapy. SNPs with very low variation in our cohort (<4% in both donor and recipient sample) were excluded from analysis. Twenty-three SNPs in 17 genes affecting glucocorticoid pathways were included in the analysis. Our endpoints were overall response (complete or partial
| INTRODUCTION
Glucocorticoids are central to effective therapy of acute graft-versushost disease (GVHD). However, only about half of the patients respond and only one-third have a durable response. 1 Several studies have evaluated clinical and biological parameters to predict response at day 28; however, none has explored glucocorticoid pathways directly to identify steroid resistance in acute GVHD. [2] [3] [4] [5] Based on postulated mechanisms for anti-inflammatory effectiveness, 6, 7 we explored genetic variations in glucocorticoid receptor (GR), co-chaperone proteins, membrane transporters, inflammatory mediators, and variants in the T-cell receptor complex in hematopoietic cell transplant (HCT) recipients with acute GVHD requiring treatment with steroids and their donors toward response at day 28 after initiation of therapy.
| PATIENTS AND METHODS
A total of 175 HCT recipients with acute graft-versus-host disease 8 requiring treatment with systemic steroids, who underwent a HCT be- 
| RESULTS
Recipients ranged in age from <1 to 68 years, 63% underwent a HCT using a myeloablative conditioning, and 29% underwent a HCT from an HLA-identical sibling donor, 26% from matched URD, and 39% from an umbilical cord blood ( Results of analysis are presented in Table 2 . The reference category was the genotype consisting of two copies of the more common allele. The odds ratio represents the change in odds for each copy of the less common allele. The Holm-Sidak 10 method was used to adjust P-values for multiple testing. This method attempts to control the family-wise error rate at no more than 5%. All SNPs were checked for Hardy-Weinberg equilibrium. SNPs rs864058 and rs179008 (both in TLR7 gene) were identified not to be in Hardy-Weinberg equilibrium (P<.02).
Outcomes evaluated include complete response (CR) and complete or partial response (CR/PR). After excluding SNPs that were not in Hardy-Weinberg equilibrium, donor SNP rs3192177 in the ZAP70 gene and donor SNP rs34471628 in the DUSPI gene were significantly associated with CR/PR. However, after adjustment for multiple testing, none of the SNPs remained statistically significant. T A B L E 1 (Continued) 
| DISCUSSION
T cells have been shown to be critical cellular targets of GR signaling as T-cell-specific GR knockout mice show significant mortality following immune activation. 11 It has been shown that T cells defective in Zap70 signaling show loss of retinoid receptor-dependent transcription. 12 It has also been demonstrated that Zap70 signaling is also essential in dexamethasone inducible GR-mediated transactivation in T lymphocytes. 13 Zap70 and its upstream kinase Lck have been identified to be essential enzymes in maintaining normal levels of ANXA1, a protein known to be induced and released by the glucocorticoid action. Zap70 and Lck were also found to regulate ANXA1
promoter function in part through the modulation of GR-dependent transcription. We also acknowledge all centers who enrolled in the BMT CTN 0302 trial.
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